276 results on '"Tan, Lip-Bun"'
Search Results
2. Principles of Treatment and Pharmacotherapy
3. Cardiogenic Shock : Physiological and Biochemical Concepts
4. A study of presbycardia, with gender differences favoring ageing women
5. A Mechanistic Investigation Into How Long-Term Resynchronization Therapy Confers Ongoing Cardiac Functional Benefits and Improved Exercise Capacity
6. Is uremic cardiomyopathy a direct consequence of chronic kidney disease?
7. Efficacy of lifestyle intervention on peak exercise cardiac power output and reserve in premenopausal obese females: A randomised pilot study
8. Relative toxicity of cardiotonic agents: Some induced more cardiac and skeletal myocyte apoptosis and necrosis in vivo than others
9. How do different indicators of cardiac pump function impact upon the long-term prognosis of patients with chronic heart failure?
10. Discrepancy Between Cardiac and Physical Functional Reserves in Stroke
11. Chapter 11 Heart failure in the elderly
12. Principles governing heart failure therapy re-examined relative to standard evidence-based medicine-driven guidelines
13. Short-Axis 2D Strain from Speckle Tracking Predicts Echocardiographic Response to Cardiac Resynchronization Therapy
14. So many definitions of heart failure: are they all universally valid? A critical appraisal
15. Peak exercise responses in heart failure: back to basics
16. A prospective longitudinal evaluation of the benefits of epicardial lead placement for cardiac resynchronization therapy
17. Reduced cardiac functional reserve and quality of life in adults with GH deficiency
18. Cardio-respiratory Fitness Affects Glucose Control And Thus Cardiovascular Disease Risk In Postmenopausal Women.: 2718: Board #112 May 29 2:00 PM - 3:30 PM
19. Cardiac Functional Reserve is Diminished in Growth Hormone-Deficient Adults
20. Confusion over thiazolidinedione-induced heart failure: need for a better definition of heart failure
21. Relative myotoxic and haemodynamic effects of the β-agonists fenoterol and clenbuterol measured in conscious unrestrained rats
22. Dose-dependent separation of the hypertrophic and myotoxic effects of the β2-adrenergic receptor agonist clenbuterol in rat striated muscles
23. Correcting Data for Body Size May Confound Results
24. Impaired left ventricular function in obesity?
25. DOSE-DEPENDENT APOPTOTIC AND NECROTIC MYOCYTE DEATH INDUCED BY THE β2-ADRENERGIC RECEPTOR AGONIST, CLENBUTEROL
26. Angiotensin II induces apoptosis in vivo in skeletal, as well as cardiac, muscle of the rat
27. Exercise Duration and Peak Systolic Blood Pressure Are Predictive of Mortality in Ambulatory Patients with Mild-Moderate Chronic Heart Failure
28. Relationship of Serum Cardiac Markers following Successful Percutaneous Coronary Intervention and Subsequent Exercise Capacity in Patients with Chronic Stable Angina: A Pilot Study
29. Fiftieth anniversary of aldosterone: from discovery to cardiovascular therapy
30. Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways?
31. Assessing the effect of ACE inhibitors on exercise tolerance: a question of study design
32. Transmyocardial Laser Revascularization
33. Transmyocardial laser revascularisation in clinical practice
34. Characterisation of isoprenaline myotoxicity on slow-twitch skeletal versus cardiac muscle
35. Adverse event with first-dose perindopril in congestive heart failure
36. Interpretation of IST and CAST stroke trials
37. Measurement of plasma brain natriuretic peptide in heart failure
38. Transmyocardial laser revascularization
39. Measurement of cardiac reserve in cardiogenic shock: implications for prognosis and management
40. Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure
41. VALUE: analysis of results
42. 200+ years of a misunderstood drug for treating chronic heart failure: Digoxin, why and how should we continue using it?
43. 93 Does Intervention of Severe Valve Lesions always Improve Cardiac Function?
44. 36 Direct Measurement of Cardiac Compensation in Valvular Heart Disease
45. SP445CARDIAC AND NON-CARDIAC DETERMINANTS OF EXERCISE CAPACITY IN ASYMPTOMATIC NON-DIABETIC CHRONIC KIDNEY DISEASE PATIENTS
46. New evidence of cardiac dysfunction associated with renal impairment
47. Cardiogenic Shock: Physiological and Biochemical Concepts
48. Atrial Fibrillation reduces the Functional REServe of the Heart by a fifth: A pilot FRESH-AF study
49. 148. Cardiac power output and age-related changes in healthy women
50. Cardiac functional benefits of ivabradine therapy in patients with severe heart failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.